Dave Ricks Headshot
Report a problem with this profile
[email protected]

Dave Ricks    

CEO of Eli Lily

Dave Ricks is the CEO of Eli Lilly, a position he assumed in January 2017. He also serves as the chair of the company’s board of directors since June 2017. Ricks' dedication to the power of science and technology has been a driving force in his role at Eli Lilly, where he and his team have consistently pursued complex diseases and accelerated the delivery of new medicines worldwide. With Ricks at the helm, the company has made significant strides in helping millions of people manage illnesses like diabetes, obesity, and autoimmune conditions.

One of Ricks' notable contributions to the field of medicine has been his involvement in the successful implementation of GLP-1-based medicines like "Tirzepatide." This medication has significantly impacted the treatment of diseases such as diabetes and obesity. His strategic decisions and focused leadership have played a substantial role in establishing Eli Lilly as the most valuable pharmaceutical company globally.

In addition to his role at Eli Lilly, Ricks is a prominent figure in various prestigious industry boards. He serves on the board of Adobe and is the immediate past chair of the board of the Pharmaceutical Research and Manufacturers of America. His influence extends to the International Federation of Pharmaceutical Manufacturers & Association’s CEO Steering Committee, The Business Council, Business Roundtable, and the U.S. Patent and Trademark Office’s Council for Inclusive Innovation.

Notwithstanding his numerous accomplishments, Ricks is known for his humility, fierce determination, and approachability. He also serves as a digital media spokesperson for Lilly, providing insight on topics related to the company, its business, and the broader healthcare environment.

Related Speakers View all


More like Dave